Former Capitol Police Officer Michael Fanone Was Out of Control During Jack Smith's...
Darrell Issa's Questions for Jack Smith Did Not Sit Well With Dems
Jim Jordan Gets Jack Smith to Admit How Far He Was Willing to...
Governors Newsom and Walz Lurch Toward Infanticide
Don Lemon Walks Free While Someone Else Takes the Fall in Church Protest...
Passengers Applaud After Woman Kicked Off Miami Flight Following Bizarre Political Rant
Nick Shirley Gave Opening Remarks at the House Judiciary Committee Hearing on Fraud....
DHS: Palestinian Activist Mahmoud Khalil Will Be Rearrested and Deported to Algeria
Javier Milei Declares the United States a 'Beacon of Liberty' at the World...
The First Son, Credited With Saving the Life of a 'Very Close' Female...
DHS Slams Democrat Story Which Claims ICE Used 5-Year-Old As Bait
The Trump Administration Is Actively Seeking Regime Change in Cuba by the End...
U.S. House Approves $10B for ICE Funding, Avoids Shutdown
Jury Convicts California Couple Charged with $100 Million Fraud
Two Men Sentenced in Nearly $2M COVID-19 Relief Fraud Scheme
Tipsheet

Pfizer CEO: Our Vaccines Offer ‘Limited, If Any Protection’

AP Photo/Pablo Martinez Monsivais, File

Speaking during remarks to a J.P. Morgan healthcare conference this week, Pfizer CEO Albert Bourla openly stated current vaccines the company developed for Wuhan coronavirus offer "limited, if any" protection against contracting current variants of the disease. He then encouraged booster shots. 

The statement from Bourla comes as the Biden administration continues to justify vaccine mandates for federal workers, contractors and private businesses. The Supreme Court heard arguments about President Biden's mandates for private companies and medical workers last week. A ruling is expected soon on the constitutionality of the mandates. 

A number of people who have pointed out the waning efficacy of Pfizer's vaccines, which Bourla touted last year as being "100 percent" effective against contracting or transmitting the virus, have been banned by social media companies. 

Meanwhile, Bourla also announced this week the company is developing a vaccine specific to Omicron. It is expected to be ready in March when health officials predict the latest wave of the mild variant will already be over. 

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos